Does a shortened hyperemia with regadenoson stress pose a concern for quantitative Rb-82 PET imaging? Optimization of regadenoson PET imaging.

نویسنده

  • Albert J Sinusas
چکیده

A lthough regadenoson has nearly replaced other vasodilator stressors for single-photon emission computed tomography perfusion imaging, the benefits of regadenoson stress for positron emission tomography (PET) perfusion are less clearly established, particularly in the estimation of absolute stress flow with dynamic PET imaging. In the estimation of absolute flow with dynamic PET, the timing of radiotracer administration needs to be carefully matched to the time and duration of coronary hyperemia. In this issue of iJACC, Johnson and Gould (1) suggest the regadenoson stress Rb-82 may underestimate flow that can be achieved with dipyridamole stress, and this underestimation is critically dependent on the timing of Rb-82 administration relative to the administration of regadenoson.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Regadenoson versus dipyridamole hyperemia for cardiac PET imaging.

OBJECTIVES The goal of this study was to compare regadenoson and dipyridamole hyperemia for quantitative myocardial perfusion imaging. BACKGROUND Regadenoson is commonly used for stress perfusion imaging. However, no study in nuclear cardiology has employed a paired design to compare quantitative hyperemic flow from regadenoson to more traditional agents such as dipyridamole. Additionally, th...

متن کامل

Detection of obstructive coronary artery disease using regadenoson stress and 82Rb PET/CT myocardial perfusion imaging.

UNLABELLED Our objective was to study the diagnostic performance of regadenoson (82)Rb myocardial perfusion PET imaging to detect obstructive coronary artery disease (CAD). METHODS We studied 134 patients (mean age, 63 ± 12 y; mean body mass index, 31 ± 9 kg/m(2)) without known CAD (96 with coronary angiography and 38 with low pretest likelihood of CAD). Stress left ventricular ejection fract...

متن کامل

Regadenoson cardiovascular magnetic resonance myocardial perfusion imaging predicts need for future revascularization

Background Regadenoson (Lexiscan; Astellas) is a new vasodilator myocardial stress agent that selectively activates the A2A receptor. Unlike adenosine, regadenoson is easier to administer and results in fewer side effects. Although extensively studied in patients undergoing nuclear myocardial perfusion imaging (MPI), its performance in cardiovascular magnetic resonance (CMR) MPI remains unknown...

متن کامل

Towards reliable myocardial blood-oxygen-level-dependent (BOLD) CMR using late effects of regadenoson with simultaneous 13n-ammonia pet validation in a whole-body hybrid PET/MR system

Background BOLD CMR is a non-contrast approach for examining myocardial perfusion but despite major technical advancements to date, its reliability remains weak. A key reason for this is the unpredictable cardiac motion during stress, which can lead to pronounced artifacts that confound/ mask the true BOLD signal changes during hyperemia. Recently, regadenoson has become the vasodilator of choi...

متن کامل

Regadenoson in the detection of coronary artery disease

Myocardial perfusion studies use either physical exercise or pharmacologic vasodilator stress to induce maximum myocardial hyperemia. Adenosine and dipyridamole are the most commonly used agents to induce coronary arterial vasodilation for myocardial perfusion imaging. Both cause frequent undesirable side-effects. Because of its ultrashort half-life, adenosine must be administered by constant i...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • JACC. Cardiovascular imaging

دوره 8 4  شماره 

صفحات  -

تاریخ انتشار 2015